Expertise in
6
conditions

Shenghong Q. Ju

Jiangsu Key Laboratory Of Molecular Imaging And Functional Imaging, 87 Dingjiaqiao Road, 
Nanjing, CN 
Expertise in
6
conditions
Jiangsu Key Laboratory Of Molecular Imaging And Functional Imaging, 87 Dingjiaqiao Road, 
Nanjing, CN 

Overview

Shenghong Ju practices practicing medicine in Nanjing, China.

Ju is highly rated in 6 conditions, according to our data. Their clinical expertise encompasses Portal Hypertension, Alternating Hemiplegia of Childhood, Hemiplegia, Hepato-Pancreato-Biliary Surgery, and Thrombectomy.

They are actively involved in clinical research, co-authoring 271 peer reviewed articles and participating in 1 clinical trial.

Locations

Jiangsu Key Laboratory Of Molecular Imaging And Functional Imaging, 87 Dingjiaqiao Road, Nanjing, 210009, China
Other Locations
Shanghai, 200240, China
Key Laboratory For Thermal Science And Power Engineering Of Ministry Of Education, Beijing, China
Jiangsu Key Laboratory Of Thin Films, Suzhou, 215006, China
The Jiangsu Key Laboratory Of Molecular And Functional Imaging, China
Nantong, 226001, China
Zhongshan, 200540, China
Jiangsu Key Laboratory Of Molecular And Functional Imaging, P.R. China, Zhomda, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

MR-based Models for Noninvasive Detection of Clinically Significant Portal Hypertension in Cirrhosis (CHESS1802)
MR-based Models for Noninvasive Detection of Clinically Significant Portal Hypertension in Cirrhosis (CHESS1802)
Enrollment Status: Completed
Publish Date: August 28, 2019
Intervention Type: Procedure
Study Phase: Not Applicable

271 Total Publications

Erratum: Co-delivery of siPTPN13 and siNOX4 via (myo)fibroblast-targeting polymeric micelles for idiopathic pulmonary fibrosis therapy: Erratum.
Erratum: Co-delivery of siPTPN13 and siNOX4 via (myo)fibroblast-targeting polymeric micelles for idiopathic pulmonary fibrosis therapy: Erratum.
Journal: Theranostics
Published: September 08, 2026

Frequently Asked Questions about Shenghong Q. Ju

Is Shenghong Q. Ju a top-rated expert for Portal Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Shenghong Q. Ju is classified as an Advanced expert for Portal Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Shenghong Q. Ju participate in research or clinical trials?

Yes. Shenghong Q. Ju has published 271 articles and abstracts on conditions like Portal Hypertension. You can view a list of Shenghong Q. Ju's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ju's expertise for a condition
ConditionClose
      View All 47 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile